Immediate and long term outcome of human parvovirus B19 infection in pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 2, 1998, Pages 174-178

  Miller, Elizabeth ^a   Fairley, Christopher K ^b   Cohen, Bernard J ^a   Seng, Claude ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGENITAL MALFORMATION; ERYTHEMA INFECTIOSUM; FETUS OUTCOME; FETUS WASTAGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PARVOVIRUS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

COHORT STUDIES; ENGLAND; FEMALE; FETAL DEATH; FOLLOW-UP STUDIES; HUMANS; HYDROPS FETALIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; WALES;

EID: 0031930637     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10048.x     Document Type: Article

References (20)

1. Brown T, Anand A, Ritchie LD, Clewley JP, Reid TMS. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984; 2: 1033–1034.
2. Cohen B. Parvovirus B19: an expanding spectrum of disease. BMJ 1995; 311: 1549–1552.
3. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy.
4. Enders G, Biber M. Parvovirus B 19 infections in pregnancy. Behring Inst Mitt 1990; 74–78.
5. Rodis JF, Quinn DL, Gary GW, Jr. et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study [see comments]. Am J Obstet Gynecol 1990; 163: 1168–1171.
6. Centre for Disease Control. Risks associated with human parvovirus B19 infection. MMWR CDC Surveill Summ 1989; 38: 81–95.
7. Rice PS, Cohen BJ. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays. Epidemiol Infect 1996; 116: 331–338.
8. Yoto Y, Kudoh T, Asanuma, H, Numazaki, K, Tsutsumi Y, Nakata S et al. Transient disturbance of consciousness and hepatic dysfunction with human parvovirus B19 infection. Lancet 1994; 344: 624–625.
9. Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial cells. Lancet 1988; 1: 535–536.
10. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994; 343: 1548–1551.
11. Pasternak AL. Levy M, Schick B, Zuber C, Feldkamp M, Gladstone J et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994; 330: 901–905.
12. Fairley CK, Smoleniec JS, Caul OE, Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995; 346; 1335–1337.
13. Gay NJ, Hesketh LM, Cohen BJ, Rush M, Bates C, Morgan-Capner P, Miller E. Age specific antibody prevalence to parvovirus B19: how may women are infected in pregnancy Commun Dis Rep CDR Rev 1994; 4: R104–R107.
14. Sillis M, White PMB, Cohen BJ. Contact with rashes during pregnancy [letter]. Lancet 1994; 343: 1439.
15. Smoleniec JS, Pillai M, EO Caul, Usher J. Subclinical transplacental parvovirus B19 infection: an increased fetal risk [letter] Lancet 1994; 343: 1100–1101.
16. Lushner JM, Zuelzer WW. Idiopathic thrombocytopenic purpura in children. Pediatr 1966; 68: 971–979.
17. Grant GA. Prevalence of iron deficiency anaemia in rural pre-school children in Northern Ireland. Br J Gen Pract 1990; 40: 112–113.
18. Davie R, Butler N, Goldstein H. From Birth to Seven. The Second Report of the National Child Development Study (1958 Cohort). London: Longman, 1972.
19. Carter AO, Frank JW. Congenital toxoplasmosis: epidemiologic features and control. Can Med Assoc J 1986; 135: 618–623.
20. Bansal GP, Hatfield JA, Dunn FE et al. Candidate recombinant vaccines for human B19 parvovirus. J Infect Dis 1993; 167: 103–144.